Company / AR per Share
Adaptimmune Therapeutics PLC AR per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.00
FY2024
5-year range
$0.00 / $0.01
FY2020-FY2024
Trend
+28.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
AR per Share has fluctuated over the past 8 years, ranging from $0.00 in FY2020 to $0.01 in FY2022.
Based on SEC 10-K filings.
0.00 in FY2024 with a 3-year CAGR of +9.6%.
Declined from $0.01 to $0.00 over the past 2 years.
AR per Share over time
Growth rates
- 3-Year CAGR
- +9.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, ar per share increased 28.3% year-over-year.
- Peak ar per share was recorded in FY2022.
- Lowest ar per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -3.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | +28.3% |
| FY2023 | $0.00 | -89.6% |
| FY2022 | $0.01 | +888.9% |
| FY2021 | $0.00 | +267.6% |
| FY2020 | $0.00 | - |
| FY2019 | - | - |
| FY2018 | $0.00 | -29.6% |
| FY2017 | $0.00 | -86.1% |
| FY2016 | $0.00 | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026